Literature DB >> 11868790

Progress in surgical treatment of hepatocellular carcinoma.

Masatoshi Makuuchi1, Hiroshi Imamura, Yasuhiko Sugawara, Tadatoshi Takayama.   

Abstract

Surgery for hepatocellular carcinoma has improved dramatically during the last two decades, and the improvement is mainly attributable to the development of intraoperative ultrasound-guided operative procedures such as Makuuchi's segmentectomy, introduction of the intermittent vascular occlusion technique, and establishment of the precise criteria for indications of various hepatectomy procedures. The use of preoperative portal vein embolization for inducing compensatory hypertrophy of remnant liver in the future has increased the safety and extended indications of hepatectomy for hepatocellular carcinoma. Operative mortality has fallen below 2% in the 1990s, with the 5-year survival rate reaching nearly 50% in a recent nationwide survey in Japan. More than 90% of hepatectomies at our institution are performed without red blood cell transfusions, and the mean hospital stay is shortened to approximately 23 days. Moreover, not a single case of operative death has been recorded since 1993.

Entities:  

Mesh:

Year:  2002        PMID: 11868790     DOI: 10.1159/000048280

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  25 in total

1.  Ultrasound-guided microwave coagulation assists anatomical hepatic resection.

Authors:  Satoru Imura; Mitsuo Shimada; Tohru Utsunomiya; Yuji Morine; Tetsuya Ikemoto; Hiroki Mori; Jun Hanaoka; Shuichi Iwahashi; Yu Saito; Hidenori Miyake
Journal:  Surg Today       Date:  2011-11-12       Impact factor: 2.549

2.  Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Dig Dis Sci       Date:  2012-03-11       Impact factor: 3.199

3.  Usefulness of absorbable sutures in preventing surgical site infection in hepatectomy.

Authors:  Shinji Togo; Toru Kubota; Takuji Takahashi; Kenichi Yoshida; Kenichi Matsuo; Daisuke Morioka; Kuniya Tanaka; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2008-06       Impact factor: 3.452

4.  Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC).

Authors:  Si-Yuan Tian; Shou-Hua Chen; Bing-Feng Shao; Hong-Yu Cai; Yuan Zhou; Yi-Long Zhou; Ai-Bing Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Authors:  Gang Wang; Jia-Hui Chen; Yong Qiang; Dong-Zhi Wang; Zhong Chen
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

6.  Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.

Authors:  Hsiao-Tien Liu; Shao-Bin Cheng; Cheng-Chung Wu; Hong-Zen Yeh; Chi-Sen Chang; John Wang
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

7.  Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma.

Authors:  Karim M Eltawil; Mark Kidd; Francesco Giovinazzo; Ahmed H Helmy; Ronald R Salem
Journal:  World J Surg Oncol       Date:  2010-05-24       Impact factor: 2.754

8.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma.

Authors:  M Abu-Hilal; J N Primrose; A Casaril; M J W McPhail; N W Pearce; N Nicoli
Journal:  J Gastrointest Surg       Date:  2008-07-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.